United States Ophthalmic Drugs Market Report 2016

Global Info Research
120 Pages
Notes:
Sales, means the sales volume of Ophthalmic Drugs
Revenue, means the sales value of Ophthalmic Drugs

This report studies sales (consumption) of Ophthalmic Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Novartis
Santen Pharmaceutical
Merck
Roche Holding AG
Pfizer
Allergan
Valeant
Regeneron
Bayer
Senju
Akorn

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Prescription Drugs
OTC Drugs
Type III
Split by applications, this report focuses on sales, market share and growth rate of Ophthalmic Drugs in each application, can be divided into
Dry Eye Drugs
Retinal Drugs
Anti-inflammatory/allergy/infective Drugs
Anti-glaucoma Drugs
Others

Table of Contents



United States Ophthalmic Drugs Market Report 2016

1 Ophthalmic Drugs Overview

1.1 Product Overview and Scope of Ophthalmic Drugs

1.2 Classification of Ophthalmic Drugs

1.2.1 Prescription Drugs

1.2.2 OTC Drugs

1.2.3 Type III

1.3 Application of Ophthalmic Drugs

1.3.1 Dry Eye Drugs

1.3.2 Retinal Drugs

1.3.3 Anti-inflammatory/allergy/infective Drugs

1.3.4 Anti-glaucoma Drugs

1.3.5 Others

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Ophthalmic Drugs (2011-2021)

1.4.1 United States Ophthalmic Drugs Sales and Growth Rate (2011-2021)

1.4.2 United States Ophthalmic Drugs Revenue and Growth Rate (2011-2021)



2 United States Ophthalmic Drugs Competition by Manufacturers

2.1 United States Ophthalmic Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Ophthalmic Drugs Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Ophthalmic Drugs Average Price by Manufactures (2015 and 2016)

2.4 Ophthalmic Drugs Market Competitive Situation and Trends

2.4.1 Ophthalmic Drugs Market Concentration Rate

2.4.2 Ophthalmic Drugs Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion



3 United States Ophthalmic Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Ophthalmic Drugs Sales and Market Share by Type (2011-2016)

3.2 United States Ophthalmic Drugs Revenue and Market Share by Type (2011-2016)

3.3 United States Ophthalmic Drugs Price by Type (2011-2016)

3.4 United States Ophthalmic Drugs Sales Growth Rate by Type (2011-2016)



4 United States Ophthalmic Drugs Sales (Volume) by Application (2011-2016)

4.1 United States Ophthalmic Drugs Sales and Market Share by Application (2011-2016)

4.2 United States Ophthalmic Drugs Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities



5 United States Ophthalmic Drugs Manufacturers Profiles/Analysis

5.1 Novartis

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Ophthalmic Drugs Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Novartis Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Santen Pharmaceutical

5.2.2 Ophthalmic Drugs Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Santen Pharmaceutical Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Merck

5.3.2 Ophthalmic Drugs Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Merck Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Roche Holding AG

5.4.2 Ophthalmic Drugs Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Roche Holding AG Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Pfizer

5.5.2 Ophthalmic Drugs Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Pfizer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Allergan

5.6.2 Ophthalmic Drugs Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Allergan Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Valeant

5.7.2 Ophthalmic Drugs Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Valeant Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Regeneron

5.8.2 Ophthalmic Drugs Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Regeneron Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Bayer

5.9.2 Ophthalmic Drugs Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Bayer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Senju

5.10.2 Ophthalmic Drugs Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Senju Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Akorn



6 Ophthalmic Drugs Manufacturing Cost Analysis

6.1 Ophthalmic Drugs Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Ophthalmic Drugs



7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Ophthalmic Drugs Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Ophthalmic Drugs Major Manufacturers in 2015

7.4 Downstream Buyers



8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List



9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change



10 United States Ophthalmic Drugs Market Forecast (2016-2021)

10.1 United States Ophthalmic Drugs Sales, Revenue Forecast (2016-2021)

10.2 United States Ophthalmic Drugs Sales Forecast by Type (2016-2021)

10.3 United States Ophthalmic Drugs Sales Forecast by Application (2016-2021)

10.4 Ophthalmic Drugs Price Forecast (2016-2021)



11 Research Findings and Conclusion



12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer




List of Tables and Figures



Figure Picture of Ophthalmic Drugs

Table Classification of Ophthalmic Drugs

Figure United States Sales Market Share of Ophthalmic Drugs by Type in 2015

Figure Prescription Drugs Picture

Figure OTC Drugs Picture

Table Application of Ophthalmic Drugs

Figure United States Sales Market Share of Ophthalmic Drugs by Application in 2015

Figure Dry Eye Drugs Examples

Figure Retinal Drugs Examples

Figure Anti-inflammatory/allergy/infective Drugs Examples

Figure Anti-glaucoma Drugs Examples

Figure Others Examples

Figure United States Ophthalmic Drugs Sales and Growth Rate (2011-2021)

Figure United States Ophthalmic Drugs Revenue and Growth Rate (2011-2021)

Table United States Ophthalmic Drugs Sales of Key Manufacturers (2015 and 2016)

Table United States Ophthalmic Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Ophthalmic Drugs Sales Share by Manufacturers

Figure 2016 Ophthalmic Drugs Sales Share by Manufacturers

Table United States Ophthalmic Drugs Revenue by Manufacturers (2015 and 2016)

Table United States Ophthalmic Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Ophthalmic Drugs Revenue Share by Manufacturers

Table 2016 United States Ophthalmic Drugs Revenue Share by Manufacturers

Table United States Market Ophthalmic Drugs Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Ophthalmic Drugs Average Price of Key Manufacturers in 2015

Figure Ophthalmic Drugs Market Share of Top 3 Manufacturers

Figure Ophthalmic Drugs Market Share of Top 5 Manufacturers

Table United States Ophthalmic Drugs Sales by Type (2011-2016)

Table United States Ophthalmic Drugs Sales Share by Type (2011-2016)

Figure United States Ophthalmic Drugs Sales Market Share by Type in 2015

Table United States Ophthalmic Drugs Revenue and Market Share by Type (2011-2016)

Table United States Ophthalmic Drugs Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Ophthalmic Drugs by Type (2011-2016)

Table United States Ophthalmic Drugs Price by Type (2011-2016)

Figure United States Ophthalmic Drugs Sales Growth Rate by Type (2011-2016)

Table United States Ophthalmic Drugs Sales by Application (2011-2016)

Table United States Ophthalmic Drugs Sales Market Share by Application (2011-2016)

Figure United States Ophthalmic Drugs Sales Market Share by Application in 2015

Table United States Ophthalmic Drugs Sales Growth Rate by Application (2011-2016)

Figure United States Ophthalmic Drugs Sales Growth Rate by Application (2011-2016)

Table Novartis Basic Information List

Table Novartis Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis Ophthalmic Drugs Sales Market Share (2011-2016)

Table Santen Pharmaceutical Basic Information List

Table Santen Pharmaceutical Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Santen Pharmaceutical Ophthalmic Drugs Sales Market Share (2011-2016)

Table Merck Basic Information List

Table Merck Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck Ophthalmic Drugs Sales Market Share (2011-2016)

Table Roche Holding AG Basic Information List

Table Roche Holding AG Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Roche Holding AG Ophthalmic Drugs Sales Market Share (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Ophthalmic Drugs Sales Market Share (2011-2016)

Table Allergan Basic Information List

Table Allergan Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Allergan Ophthalmic Drugs Sales Market Share (2011-2016)

Table Valeant Basic Information List

Table Valeant Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Valeant Ophthalmic Drugs Sales Market Share (2011-2016)

Table Regeneron Basic Information List

Table Regeneron Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Regeneron Ophthalmic Drugs Sales Market Share (2011-2016)

Table Bayer Basic Information List

Table Bayer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer Ophthalmic Drugs Sales Market Share (2011-2016)

Table Senju Basic Information List

Table Senju Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Senju Ophthalmic Drugs Sales Market Share (2011-2016)

Table Akorn Basic Information List

Table Akorn Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2011-2016)

Table Akorn Ophthalmic Drugs Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Ophthalmic Drugs

Figure Manufacturing Process Analysis of Ophthalmic Drugs

Figure Ophthalmic Drugs Industrial Chain Analysis

Table Raw Materials Sources of Ophthalmic Drugs Major Manufacturers in 2015

Table Major Buyers of Ophthalmic Drugs

Table Distributors/Traders List

Figure United States Ophthalmic Drugs Production and Growth Rate Forecast (2016-2021)

Figure United States Ophthalmic Drugs Revenue and Growth Rate Forecast (2016-2021)

Table United States Ophthalmic Drugs Production Forecast by Type (2016-2021)

Table United States Ophthalmic Drugs Consumption Forecast by Application (2016-2021)

captcha Cheak Discount
 
Can't read the image? click here to refresh
* mark fields are compulsory

United States Topical Skin Adhesive Market by Manufacturers, States, Type and Application, Forecast to 2022

GIR 2017-10-10 Pharma & Healthcare

"Topical skin adhesive is a wound closure device that is fast, precise and easy to use. Topical ski...Read More

United States Hyaluronic Acid Dermal Filler Market by Manufacturers, States, Type and Application, Forecast to 2022

GIR 2017-10-10 Pharma & Healthcare

This report studies the Middle East Hyaluronic Acid Dermal Filler market, Hyaluronic Acid Dermal Fil...Read More

United States Capecitabine Market by Manufacturers, States, Type and Application, Forecast to 2022

GIR 2017-10-10 Pharma & Healthcare

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic br...Read More

Report's License Type

$3800
$7600

Related Keywords

If you are facing any issues while making the payment, you can contact us on

+1-888-376-9998
sales@globalinforeports.com

We will be happy to assist you.